Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

Meets

22 posts
OOslo
Bjorn Ahlander (right), captain of the Draken Harald Harfagre (the ship used in the movie the Odyssey) is pictured on board as the ship is docked outside Oslo Opera in the Norweigen capital.
Read More

It’s a case of history meets Hollywood

  • 2026-08-19
The eras of “The Odyssey” and the Vikings happened about 2,000 years apart — so how did a…
BBrussels
Holguín Meets von der Leyen and Fitto in Brussels
Read More

Holguín Meets von der Leyen and Fitto in Brussels

  • 2026-07-23
UN Secretary-General’s Personal Envoy on Cyprus María Ángela Holguín met European Commission President Ursula von der Leyen and…
NNovo Nordisk
Novo Nordisk’s Rally Meets a Revenue Reckoning: Buyback Momentum Clashes with 2026 Guidance
Read More

Novo Nordisk’s Rally Meets a Revenue Reckoning: Buyback Momentum Clashes with 2026 Guidance

  • 2026-07-17
Novo Nordisk has staged a striking recovery over the past month, with the stock climbing 17% even as…
NNovo Nordisk
Novo Nordisk’s Rally Faces a Test: Medicare Tailwinds Meets Analyst Caution and a Billion-Dollar P
Read More

Novo Nordisk’s Rally Faces a Test: Medicare Tailwinds Meets Analyst Caution and a Billion-Dollar P

  • 2026-07-06
The past month has brought some much-needed relief to Novo Nordisk shareholders. After shedding nearly a third of…
NNovo Nordisk
Novo Nordisk's Record Pill Launch Meets a Cybersecurity Reality Check
Read More

Novo Nordisk’s Record Pill Launch Meets a Cybersecurity Reality Check

  • 2026-06-16
The Danish drugmaker is living two parallel stories this quarter. One is about the Wayovy pill smashing prescription…
NNovo Nordisk
Novo Nordisk’s Pill Breakthrough Meets a Cybersecurity Reality Check
Read More

Novo Nordisk’s Pill Breakthrough Meets a Cybersecurity Reality Check

  • 2026-06-13
The same week that brought Novo Nordisk a historic regulatory green light for its oral weight-loss pill also…
VVilnius
AB Akola Group presentation at Nasdaq Vilnius CEO Meets Investors webinar
Read More

AB Akola Group presentation at Nasdaq Vilnius CEO Meets Investors webinar

  • 2026-06-04
On 4 June 2026, AB Akola Group participated in the virtual investor event “CEO Meets Investors”, organized by…
NNovo Nordisk
Novo Nordisk Bets on Buybacks and Pipeline Data as Prescription Boom Meets Washington Pricing Pressu
Read More

Novo Nordisk Bets on Buybacks and Pipeline Data as Prescription Boom Meets Washington Pricing Pressu

  • 2026-06-02
Novo Nordisk’s oral obesity therapy drives 2M prescriptions in 5 months, but shares tumble 48% from peak amid…
NNovo Nordisk
Novo Nordisk's Summer of Reckoning: Prescription Dominance Meets Pipeline Verdict
Read More

Novo Nordisk’s Summer of Reckoning: Prescription Dominance Meets Pipeline Verdict

  • 2026-06-02
Novo Nordisk’s oral Wegovy prescriptions outpace Eli Lilly’s Foundayo 2.4x, yet shares are down 45% from highs. Upcoming…
NNovo Nordisk
Novo Nordisk Enters a Pivotal Week: Pipeline Data Meets a Skeptical Market
Read More

Novo Nordisk Enters a Pivotal Week: Pipeline Data Meets a Skeptical Market

  • 2026-05-31
Novo Nordisk shares slide 35% in 12 months as market awaits pivotal CagriSema Phase 3 results at ADA.…
NNovo Nordisk
Novo Nordisk's Double Play: Digital Authority Meets Clinical Depth as Semaglutide's Reach Widens
Read More

Novo Nordisk’s Double Play: Digital Authority Meets Clinical Depth as Semaglutide’s Reach Widens

  • 2026-05-21
Wegovy tops AI searches; semaglutide shows 63% MASH resolution; oral pill gains momentum. Novo Nordisk faces mixed Q1…
NNovo Nordisk
Novo Nordisk's Billion-Dollar Buyback Meets a Pricing Squeeze and Digital Dominance in Obesity Marke
Read More

Novo Nordisk’s Billion-Dollar Buyback Meets a Pricing Squeeze and Digital Dominance in Obesity Marke

  • 2026-05-21
Novo Nordisk repurchases billions in B-shares amid 44% stock drop, buoyed by strong Wegovy sales and a digital…
Denmark
www.europesays.com